NEXTBIO CAPITAL MANAGEMENT LP
Q4 2025 Form 13-F

MENLO PARK, DELAWARE
CIK 0002038158 · Institutional investment manager
$170.5M Reported Value Total
Reported value
$170.5M
Quarter over quarter
0.0%
Holdings
23
Top-10 concentration
70.0%

Key People

Named on the latest Form 13-F filing — not necessarily an owner
Ky Phan
CHIEF FINANCIAL OFFICER

Filing Navigation

13F Metrics

Loading 13F Metrics

Q4 2025 13F record

Q4 2025 13F filing summary

Q4 2025 Form 13F portfolio summary
Period of report December 31, 2025
Filed February 13, 2026
Form 13F-HR
Reported value $170.5M
Positions 23
Change in reported value First reported quarter
Top-10 concentration 70.0%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 13, 2026
25 $234.4M
Q2 2026 13F
Filed Aug 14, 2026
22 $217.4M
Q1 2026 13F
Filed May 14, 2026
24 $215.4M
Q4 2025 13F
Filed Feb 13, 2026
23 $170.5M

Top 20 holdings · Q4 2025

Largest Q4 2025 13F positions by reported value
# Holding Reported value % of portfolio
1 TERN TERNS PHARMACEUTICALS INC $22.3M 13.06%
2 PTGX PROTAGONIST THERAPEUTICS INC $20.1M 11.76%
3 VOR VOR BIOPHARMA INC $13.1M 7.67%
4 ZBIO ZENAS BIOPHARMA INC $11.7M 6.86%
5 STTK SHATTUCK LABS INC $11.5M 6.74%
6 VSTM VERASTEM INC $10.1M 5.92%
7 PVLA PALVELLA THERAPEUTICS INC NE $8.7M 5.08%
8 XENE XENON PHARMACEUTICALS INC $8.2M 4.83%
9 RYTM RHYTHM PHARMACEUTICALS INC $7.2M 4.24%
10 GPCR STRUCTURE THERAPEUTICS INC $6.6M 3.85%
11 IVA INVENTIVA SA $6.0M 3.54%
12 CMPX COMPASS THERAPEUTICS INC $6.0M 3.51%
13 CMPS COMPASS PATHWAYS PLC $5.2M 3.05%
14 ORIC ORIC PHARMACEUTICALS INC $5.0M 2.95%
15 CBIO CRESCENT BIOPHARMA INC. $4.4M 2.59%
16 PCVX VAXCYTE INC $4.4M 2.58%
17 EVMN EVOMMUNE INC $3.9M 2.29%
18 COGT COGENT BIOSCIENCES INC $3.4M 2.0%
19 IRON DISC MEDICINE INC $3.4M 1.99%
20 OCS OCULIS HOLDING AG $3.0M 1.75%

Values as reported on the Q4 2025 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings